Hancock Health and Arrive AI Launch Robotic Delivery Program to Transform Medical Logistics

Hancock Health and Arrive AI have initiated a two-year partnership that marks Arrive AI's first revenue-generating deployment of autonomous delivery technology in healthcare settings. The collaboration focuses on exploring asynchronous robotic automation for medical deliveries within hospitals, with the goal of achieving significant cost savings through technological advancements and operational efficiencies. Operations commenced with the installation of Arrive AI's patented Arrive Point, a secure autonomous delivery station that serves as a chain-of-custody-compliant hub for biospecimen transfers from the cancer center.

Steve Long, President and CEO of Hancock Health, emphasized that embracing automation enables transformative improvements in healthcare delivery. "Our top priority is delivering personalized and high-quality care in the most affordable and efficient way possible," Long stated. The initiative addresses operational inefficiencies identified by Hancock Health, where medical personnel currently make more than a dozen daily trips between clinics and hospital laboratories to deliver specimens. These manual transports pull staff from critical duties, delay lab results, and increase labor costs.

Dan O'Toole, CEO of Arrive AI, described the deployment as a significant milestone for the company. "This live deployment marks a significant milestone for Arrive AI as we move from pilot programs to generating revenue and demonstrating the real-world value of our autonomous delivery solutions," O'Toole commented. The partnership positions Hancock Health at the forefront of autonomous medical logistics, with potential applications across its broader network of more than 30 locations in East Central Indiana.

The multi-phase implementation includes comprehensive readiness evaluation, robotic technology installation at the Sue Ann Wortman Cancer Center and laboratory, development of optimized delivery routes, expansion to off-campus locations, and introduction of drone-based transport for time-sensitive medical deliveries. Each phase incorporates the Arrive Point technology, providing standardized and secure interfaces for all chain-of-custody transfers. According to the agreement terms, Arrive AI anticipates leveraging insights from this trial by September 2027 to develop a scalable framework integrating ground robotics, courier networks, and drones across Hancock Health's entire network.

Key efficiency strategies include replacing manual specimen transport with robotic automation, providing Arrive Point storage devices for 24/7 deliveries, and deploying drones for urgent and off-campus transport needs. Arrive AI will lead the design, deployment, and optimization of this integrated system, ensuring regulatory compliance, operational feasibility, and validated return on investment. The technology aims to strengthen security and reliability of medical services while accelerating delivery of critical items like test results, medications, and lab specimens, ultimately enhancing the overall patient experience through improved operational efficiency.